{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:11:10Z","timestamp":1793373070341,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":71,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Glioblastoma (GBM) is a notoriously lethal brain tumor, primarily owing to its inevitable resistance to temozolomide (TMZ), a frontline chemotherapy. Hypoxia-driven metabolic adaptations have been implicated in therapeutic failure; however, the role of circular RNAs remains largely underexplored. By integrating multiomics profiling with functional assays in patient-derived GBM cells, orthotopic xenografts, and clinical specimens, this study aimed to elucidate the role of hypoxia-induced hsa_circ_0000745 (circSPECC1) in mediating TMZ resistance. Mechanistic investigation included RNA pulldown, RIP, glycolysis flux analysis, and DNA damage assessment. The circSPECC1 is overexpressed in GBM and correlates with poor prognosis. Hypoxia triggers HIF-1\u03b1-mediated transcriptional upregulation of circSPECC1, which scaffolds insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) to stabilize phosphoglycerate kinase 1 (PGK1) mRNA. Importantly, circSPECC1\/PGK1 axis activation enhances glycolytic flux, blunts TMZ-induced DNA damage, and confers chemoresistance. Targeting circSPECC1 disrupts PGK1-driven glycolysis, restores TMZ sensitivity, and synergizes with TMZ to extend survival in orthotopic GBM models. In conclusion, this study identifies a previously uncharacterized HIF-1\u03b1\/circSPECC1\/IGF2BP2\/PGK1 axis that drives metabolic adaptation and TMZ resistance in GBM. Targeting this axis overcomes acquired chemoresistance, positioning circSPECC1 as both a prognostic biomarker and a therapeutic vulnerability in hypoxic GBM niches.<\/jats:p>","DOI":"10.1038\/s41419-026-08879-8","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T14:46:12Z","timestamp":1781707572000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hypoxia-induced circSPECC1 drives temozolomide resistance in glioblastoma via IGF2BP2-mediated PGK1 mRNA stabilization"],"prefix":"10.1038","volume":"17","author":[{"given":"Yu","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianshi","family":"Que","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaihua","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xizhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0621-0598","authenticated-orcid":false,"given":"Xuhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0894-6944","authenticated-orcid":false,"given":"Wenchuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9869-4036","authenticated-orcid":false,"given":"Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"8879_CR1","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1001\/jama.2023.0023","volume":"329","author":"LR Schaff","year":"2023","unstructured":"Schaff LR, Mellinghoff IK. Glioblastoma and other primary brain malignancies in adults: a review. JAMA. 2023;329:574\u201387.","journal-title":"JAMA"},{"key":"8879_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-024-03172-3","volume":"25","author":"G Tanner","year":"2024","unstructured":"Tanner G, Barrow R, Ajaib S, Al-Jabri M, Ahmed N, Pollock S, et al. IDHwt glioblastomas can be stratified by their transcriptional response to standard treatment, with implications for targeted therapy. Genome Biol. 2024;25:45.","journal-title":"Genome Biol"},{"key":"8879_CR3","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1001\/jamaoncol.2020.6732","volume":"7","author":"DO Kamson","year":"2021","unstructured":"Kamson DO, Grossman SA. The role of temozolomide in patients with newly diagnosed wild-type IDH, unmethylated MGMTp glioblastoma during the COVID-19 pandemic. JAMA Oncol. 2021;7:675\u20136.","journal-title":"JAMA Oncol"},{"key":"8879_CR4","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1001\/jama.2017.18718","volume":"318","author":"R Stupp","year":"2017","unstructured":"Stupp R, Taillibert S, Kanner A, Read W, Steinberg D, Lhermitte B, et al. Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial. JAMA. 2017;318:2306\u201316.","journal-title":"JAMA"},{"key":"8879_CR5","volume":"4","author":"K Seystahl","year":"2022","unstructured":"Seystahl K, Oppong FB, Le Rhun E, Hertler C, Stupp R, Nabors B, et al. Associations of levetiracetam use with the safety and tolerability profile of chemoradiotherapy for patients with newly diagnosed glioblastoma. Neurooncol Adv. 2022;4:vdac112.","journal-title":"Neurooncol Adv"},{"key":"8879_CR6","first-page":"433","volume":"21","author":"S Lai","year":"2024","unstructured":"Lai S, Li P, Liu X, Liu G, Xie T, Zhang X, et al. Efficacy and safety of anlotinib combined with the STUPP regimen in patients with newly diagnosed glioblastoma: a multicenter, single-arm, phase II trial. Cancer Biol Med. 2024;21:433\u201344.","journal-title":"Cancer Biol Med"},{"key":"8879_CR7","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1158\/1078-0432.CCR-24-2974","volume":"31","author":"D Stefan","year":"2025","unstructured":"Stefan D, Lesueur P, Lequesne J, Feuvret L, Bronnimann C, Castera M, et al. Olaparib, temozolomide, and concomitant radiotherapy for partially resected or biopsy-only glioblastoma first-line treatment: results from the OLA-TMZ-RTE-01 phase I study. Clin Cancer Res. 2025;31:1212\u201322.","journal-title":"Clin Cancer Res"},{"key":"8879_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13045-022-01235-1","volume":"15","author":"S Mirzaei","year":"2022","unstructured":"Mirzaei S, Gholami MH, Hushmandi K, Hashemi F, Zabolian A, Canadas I, et al. The long and short non-coding RNAs modulating EZH2 signaling in cancer. J Hematol Oncol. 2022;15:18.","journal-title":"J Hematol Oncol"},{"key":"8879_CR9","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41556-021-00639-4","volume":"23","author":"X Gao","year":"2021","unstructured":"Gao X, Xia X, Li F, Zhang M, Zhou H, Wu X, et al. Circular RNA-encoded oncogenic E-cadherin variant promotes glioblastoma tumorigenicity through activation of EGFR-STAT3 signalling. Nat Cell Biol. 2021;23:278\u201391.","journal-title":"Nat Cell Biol"},{"key":"8879_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01485-6","volume":"21","author":"Z Pan","year":"2022","unstructured":"Pan Z, Zhao R, Li B, Qi Y, Qiu W, Guo Q, et al. EWSR1-induced circNEIL3 promotes glioma progression and exosome-mediated macrophage immunosuppressive polarization via stabilizing IGF2BP3. Mol Cancer. 2022;21:16.","journal-title":"Mol Cancer"},{"key":"8879_CR11","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41568-024-00721-7","volume":"24","author":"VM Conn","year":"2024","unstructured":"Conn VM, Chinnaiyan AM, Conn SJ. Circular RNA in cancer. Nat Rev Cancer. 2024;24:597\u2013613.","journal-title":"Nat Rev Cancer"},{"key":"8879_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-021-00809-9","volume":"20","author":"R Salami","year":"2022","unstructured":"Salami R, Salami M, Mafi A, Vakili O, Asemi Z. Circular RNAs and glioblastoma multiforme: focus on molecular mechanisms. Cell Commun Signal. 2022;20:13.","journal-title":"Cell Commun Signal"},{"key":"8879_CR13","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41420-022-01136-9","volume":"8","author":"N Long","year":"2022","unstructured":"Long N, Xu X, Lin H, Lv Y, Zou S, Cao H, et al. Circular RNA circPOSTN promotes neovascularization by regulating miR-219a-2-3p\/STC1 axis and stimulating the secretion of VEGFA in glioblastoma. Cell Death Discov. 2022;8:349.","journal-title":"Cell Death Discov"},{"key":"8879_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01253-y","volume":"19","author":"J Lou","year":"2020","unstructured":"Lou J, Hao Y, Lin K, Lyu Y, Chen M, Wang H, et al. Circular RNA CDR1as disrupts the p53\/MDM2 complex to inhibit Gliomagenesis. Mol Cancer. 2020;19:138.","journal-title":"Mol Cancer"},{"key":"8879_CR15","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1007\/s12031-022-02090-y","volume":"72","author":"Z Chen","year":"2022","unstructured":"Chen Z, Su S, Yang M, Wang F, Chen M. Profiling and bioinformatics analyses of differential circular RNA expression in glioblastoma multiforme cells under hypoxia. J Mol Neurosci. 2022;72:2451\u201363.","journal-title":"J Mol Neurosci"},{"key":"8879_CR16","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.3724\/abbs.2023230","volume":"55","author":"P Lan","year":"2023","unstructured":"Lan P, Li M, Wang Y, Wang J, Li L, Zhang S, et al. Y-box protein-1 modulates circSPECC1 to promote glioma tumorigenesis via miR-615-5p\/HIP1\/AKT axis. Acta Biochim Biophys Sin. 2023;55:1902\u201312.","journal-title":"Acta Biochim Biophys Sin"},{"key":"8879_CR17","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s11658-024-00644-z","volume":"29","author":"C Wei","year":"2024","unstructured":"Wei C, Peng D, Jing B, Wang B, Li Z, Yu R, et al. A novel protein SPECC1-415aa encoded by N6-methyladenosine modified circSPECC1 regulates the sensitivity of glioblastoma to TMZ. Cell Mol Biol Lett. 2024;29:127.","journal-title":"Cell Mol Biol Lett"},{"key":"8879_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e28785","volume":"10","author":"H Chen","year":"2024","unstructured":"Chen H, Wang X, Cheng H, Deng Y, Chen J, Wang B. CircRNA circRREB1 promotes tumorigenesis and progression of breast cancer by activating Erk1\/2 signaling through interacting with GNB4. Heliyon. 2024;10:e28785.","journal-title":"Heliyon"},{"key":"8879_CR19","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.7150\/ijbs.58035","volume":"17","author":"H Li","year":"2021","unstructured":"Li H, Wang D, Yi B, Cai H, Wang Y, Lou X, et al. SUMOylation of IGF2BP2 promotes vasculogenic mimicry of glioma via regulating OIP5-AS1\/miR-495-3p axis. Int J Biol Sci. 2021;17:2912\u201330.","journal-title":"Int J Biol Sci"},{"key":"8879_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2023.105534","volume":"166","author":"LM Tan","year":"2023","unstructured":"Tan LM, Chen P, Nie ZY, Liu XF, Wang B. Circular RNA XRCC5 aggravates glioma progression by activating CLC3\/SGK1 axis via recruiting IGF2BP2. Neurochem Int. 2023;166:105534.","journal-title":"Neurochem Int"},{"key":"8879_CR21","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s13046-023-02816-9","volume":"42","author":"C Wang","year":"2023","unstructured":"Wang C, Zhang M, Liu Y, Cui D, Gao L, Jiang Y. CircRNF10 triggers a positive feedback loop to facilitate progression of glioblastoma via redeploying the ferroptosis defense in GSCs. J Exp Clin Cancer Res. 2023;42:242.","journal-title":"J Exp Clin Cancer Res"},{"key":"8879_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06261-4","volume":"23","author":"X Li","year":"2025","unstructured":"Li X, Zhang W, Fang Y, Sun T, Chen J, Tian R. Large-scale CRISPRi screens link metabolic stress to glioblastoma chemoresistance. J Transl Med. 2025;23:289.","journal-title":"J Transl Med"},{"key":"8879_CR23","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.immuni.2024.04.006","volume":"57","author":"A De Leo","year":"2024","unstructured":"De Leo A, Ugolini A, Yu X, Scirocchi F, Scocozza D, Peixoto B, et al. Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma. Immunity. 2024;57:1105\u20131123.e1108.","journal-title":"Immunity"},{"key":"8879_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202310163","volume":"11","author":"T Li","year":"2024","unstructured":"Li T, Xu D, Ruan Z, Zhou J, Sun W, Rao B, et al. Metabolism\/immunity dual-regulation thermogels potentiating immunotherapy of glioblastoma through lactate-excretion inhibition and PD-1\/PD-L1 blockade. Adv Sci (Weinh). 2024;11:e2310163.","journal-title":"Adv Sci (Weinh)"},{"key":"8879_CR25","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s13046-023-02927-3","volume":"42","author":"HJ Yun","year":"2023","unstructured":"Yun HJ, Li M, Guo D, Jeon SM, Park SH, Lim JS, et al. AMPK-HIF-1alpha signaling enhances glucose-derived de novo serine biosynthesis to promote glioblastoma growth. J Exp Clin Cancer Res. 2023;42:340.","journal-title":"J Exp Clin Cancer Res"},{"key":"8879_CR26","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1093\/neuonc\/noae040","volume":"26","author":"S Yang","year":"2024","unstructured":"Yang S, Zhan Q, Su D, Cui X, Zhao J, Wang Q, et al. HIF1alpha\/ATF3 partake in PGK1 K191\/K192 succinylation by modulating P4HA1\/succinate signaling in glioblastoma. Neuro Oncol. 2024;26:1405\u201320.","journal-title":"Neuro Oncol"},{"key":"8879_CR27","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.molcel.2018.06.023","volume":"71","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Yu G, Chu H, Wang X, Xiong L, Cai G, et al. Macrophage-associated PGK1 phosphorylation promotes aerobic glycolysis and tumorigenesis. Mol Cell. 2018;71:201\u2013215.e207.","journal-title":"Mol Cell"},{"key":"8879_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/6956038","volume":"2023","author":"F Xie","year":"2023","unstructured":"Xie F, Shen J, Han Z, Luo W, Liao L, He J. circSPECC1 promotes proliferation and migration of LNCaP prostate cancer cells by affecting their epithelial-mesenchymal transition. J Immunol Res. 2023;2023:6956038.","journal-title":"J Immunol Res"},{"key":"8879_CR29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.15698\/cst2024.05.296","volume":"8","author":"Z Guo","year":"2024","unstructured":"Guo Z, Chen Y, Wu Y, Lian J. CircRNA regulates the liquid-liquid phase separation of ATG4B, a novel strategy to inhibit cancer metastasis? Cell Stress. 2024;8:56\u201358.","journal-title":"Cell Stress"},{"key":"8879_CR30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41588-019-0549-x","volume":"52","author":"A Abakir","year":"2020","unstructured":"Abakir A, Giles TC, Cristini A, Foster JM, Dai N, Starczak M, et al. N(6)-methyladenosine regulates the stability of RNA:DNA hybrids in human cells. Nat Genet. 2020;52:48\u201355.","journal-title":"Nat Genet"},{"key":"8879_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-01994-0","volume":"23","author":"Y Ying","year":"2024","unstructured":"Ying Y, Wu Y, Zhang F, Tang Y, Yi J, Ma X, et al. Co-transcriptional R-loops-mediated epigenetic regulation drives growth retardation and docetaxel chemosensitivity enhancement in advanced prostate cancer. Mol Cancer. 2024;23:79.","journal-title":"Mol Cancer"},{"key":"8879_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1318","volume":"13","author":"Y Shao","year":"2023","unstructured":"Shao Y, Liu Z, Song X, Sun R, Zhou Y, Zhang D, et al. ALKBH5\/YTHDF2-mediated m6A modification of circAFF2 enhances radiosensitivity of colorectal cancer by inhibiting Cullin neddylation. Clin Transl Med. 2023;13:e1318.","journal-title":"Clin Transl Med"},{"key":"8879_CR33","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/cr.2017.31","volume":"27","author":"Y Yang","year":"2017","unstructured":"Yang Y, Fan X, Mao M, Song X, Wu P, Zhang Y, et al. Extensive translation of circular RNAs driven by N(6)-methyladenosine. Cell Res. 2017;27:626\u201341.","journal-title":"Cell Res"},{"key":"8879_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.135989","volume":"280","author":"Z Liu","year":"2024","unstructured":"Liu Z, Deng K, Su Y, Zhang Z, Shi C, Wang J, et al. IGF2BP1-mediated the stability and protein translation of FGFR1 mRNA regulates myogenesis through the ERK signaling pathway. Int J Biol Macromol. 2024;280:135989.","journal-title":"Int J Biol Macromol"},{"key":"8879_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.145390","volume":"319","author":"K Yang","year":"2025","unstructured":"Yang K, Hu Y, Ma Y, Zhu Z, Dai J, Mao X, et al. CircTBCD\/IGF2BP2 complex stabilizes IGF-1R mRNA in an m6A-dependent manner to promote bone metastasis in nasopharyngeal carcinoma. Int J Biol Macromol. 2025;319:145390.","journal-title":"Int J Biol Macromol"},{"key":"8879_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/16078454.2021.2008590","volume":"27","author":"X Yang","year":"2022","unstructured":"Yang X, Li Y, Zhang Y, Liu J. Circ_0000745 promotes acute lymphoblastic leukemia progression through mediating miR-494-3p\/NET1 axis. Hematology. 2022;27:11\u201322.","journal-title":"Hematology"},{"key":"8879_CR37","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1080\/16078454.2021.1997197","volume":"26","author":"H Feng","year":"2021","unstructured":"Feng H, Li F, Tang P. Circ_0000745 regulates NOTCH1-mediated cell proliferation and apoptosis in pediatric T-cell acute lymphoblastic leukemia through adsorbing miR-193b-3p. Hematology. 2021;26:885\u201395.","journal-title":"Hematology"},{"key":"8879_CR38","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s11011-023-01332-1","volume":"39","author":"Z Cai","year":"2024","unstructured":"Cai Z, Cai Y, Huang J, Zhang J. Circ_0027446 promotes malignant development of glioblastoma by interacting with miR-346 to up-regulate PGK1. Metab Brain Dis. 2024;39:361\u201371.","journal-title":"Metab Brain Dis"},{"key":"8879_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154695","volume":"248","author":"W Xiao","year":"2023","unstructured":"Xiao W, Li P. Circ_0087862 promotes tumorigenesis and glycolysis in colorectal cancer by sponging miR-296-3p to regulate PGK1 expression. Pathol Res Pr. 2023;248:154695.","journal-title":"Pathol Res Pr"},{"key":"8879_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04625-2","volume":"22","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Wang X, Liu W, Lei T, Qiao T, Feng W, et al. CircGLIS3 promotes gastric cancer progression by regulating the miR-1343-3p\/PGK1 pathway and inhibiting vimentin phosphorylation. J Transl Med. 2024;22:251.","journal-title":"J Transl Med"},{"key":"8879_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05175-z","volume":"13","author":"K Luo","year":"2022","unstructured":"Luo K, Liu A, Wu H, Liu Q, Dai J, Liu Y, et al. CircKIF4A promotes glioma growth and temozolomide resistance by accelerating glycolysis. Cell Death Dis. 2022;13:740.","journal-title":"Cell Death Dis"},{"key":"8879_CR42","doi-asserted-by":"crossref","unstructured":"Maurer GD, Heller S, Wanka C, Rieger J, Steinbach JP. Knockdown of the TP53-induced glycolysis and apoptosis regulator (TIGAR) sensitizes glioma cells to hypoxia, irradiation and temozolomide. Int J Mol Sci. 2019;20:1061.","DOI":"10.3390\/ijms20051061"},{"key":"8879_CR43","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41374-021-00666-7","volume":"102","author":"L Jin","year":"2022","unstructured":"Jin L, Kiang KM, Cheng SY, Leung GK. Pharmacological inhibition of serine synthesis enhances temozolomide efficacy by decreasing O(6)-methylguanine DNA methyltransferase (MGMT) expression and reactive oxygen species (ROS)-mediated DNA damage in glioblastoma. Lab Invest. 2022;102:194\u2013203.","journal-title":"Lab Invest"},{"key":"8879_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01256-4","volume":"21","author":"K Zhang","year":"2023","unstructured":"Zhang K, Sun L, Kang Y. Regulation of phosphoglycerate kinase 1 and its critical role in cancer. Cell Commun Signal. 2023;21:240.","journal-title":"Cell Commun Signal"},{"key":"8879_CR45","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1080\/15548627.2017.1313945","volume":"13","author":"X Qian","year":"2017","unstructured":"Qian X, Li X, Lu Z. Protein kinase activity of the glycolytic enzyme PGK1 regulates autophagy to promote tumorigenesis. Autophagy. 2017;13:1246\u20137.","journal-title":"Autophagy"},{"key":"8879_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-025-02047-9","volume":"23","author":"F Sun","year":"2025","unstructured":"Sun F, Li W, Du R, Liu M, Cheng Y, Ma J, et al. Impact of glycolysis enzymes and metabolites in regulating DNA damage repair in tumorigenesis and therapy. Cell Commun Signal. 2025;23:44.","journal-title":"Cell Commun Signal"},{"key":"8879_CR47","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.molcel.2017.01.027","volume":"65","author":"X Qian","year":"2017","unstructured":"Qian X, Li X, Cai Q, Zhang C, Yu Q, Jiang Y, et al. Phosphoglycerate kinase 1 phosphorylates beclin1 to induce autophagy. Mol Cell. 2017;65:917\u2013931.e916.","journal-title":"Mol Cell"},{"key":"8879_CR48","doi-asserted-by":"crossref","unstructured":"Seyhan AA. Circulating liquid biopsy biomarkers in glioblastoma: advances and challenges. Int J Mol Sci. 2024;25:7974.","DOI":"10.3390\/ijms25147974"},{"key":"8879_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1039084","volume":"14","author":"X Wu","year":"2023","unstructured":"Wu X, Shi M, Lian Y, Zhang H. Exosomal circRNAs as promising liquid biopsy biomarkers for glioma. Front Immunol. 2023;14:1039084.","journal-title":"Front Immunol"},{"key":"8879_CR50","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11095-022-03433-5","volume":"40","author":"A D\u2019Souza","year":"2023","unstructured":"D\u2019Souza A, Nozohouri S, Bleier BS, Amiji MM. CNS delivery of nucleic acid therapeutics: beyond the blood-brain barrier and towards specific cellular targeting. Pharm Res. 2023;40:77\u2013105.","journal-title":"Pharm Res"},{"key":"8879_CR51","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adi2245","volume":"16","author":"SJ Barker","year":"2024","unstructured":"Barker SJ, Thayer MB, Kim C, Tatarakis D, Simon MJ, Dial R, et al. Targeting the transferrin receptor to transport antisense oligonucleotides across the mammalian blood-brain barrier. Sci Transl Med. 2024;16:eadi2245.","journal-title":"Sci Transl Med"},{"key":"8879_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-35677-w","volume":"8","author":"HC Tsai","year":"2018","unstructured":"Tsai HC, Tsai CH, Chen WS, Inserra C, Wei KC, Liu HL. Safety evaluation of frequent application of microbubble-enhanced focused ultrasound blood-brain-barrier opening. Sci Rep. 2018;8:17720.","journal-title":"Sci Rep"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08879-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08879-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08879-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T23:02:33Z","timestamp":1787785353000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08879-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8879"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08879-8","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"23 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The study was conducted in accordance with institutional and international ethical standards. The study protocol was reviewed and approved by the Ethics Committee of Xinhua Hospital (XHEC-C-2022-111-1). Written informed consent was obtained from all patients prior to sample collection, and all procedures complied with the principles of the Declaration of Helsinki. All animal experiments were approved by the Nanfang Hospital (NFYY-2020-1038) and performed in accordance with institutional guidelines for the care and use of laboratory animals.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"756"}}